{
    "eid": "2-s2.0-85069555093",
    "title": "Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial",
    "cover-date": "2019-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Antibacterial agents",
        "antibiotic regimen",
        "catheter removal",
        "cefazolin",
        "cefepime",
        "ceftazidime",
        "complete cure",
        "continuous ambulatory peritoneal dialysis (CAPD)",
        "end-stage renal disease (ESRD)",
        "monotherapy",
        "outcomes",
        "peritonitis",
        "primary response",
        "randomized controlled trial (RCT)"
    ],
    "authors": [
        "Thidarat Kitrungphaiboon",
        "Pongpratch Puapatanakul",
        "Piyatida Chuengsaman",
        "Krittaya Tiskajornsiri",
        "Guttiga Halue",
        "Monchai Siribamrungwong",
        "Saraporn Matayart",
        "Kamonrat Chongthanakorn",
        "Ussanee Poonvivatchaikarn",
        "Chanchana Boonyakrai",
        "Wanida Somboonsilp",
        "Pisut Katavetin",
        "Kearkiat Praditpornsilpa",
        "Somchai Eiam-Ong",
        "David W. Johnson",
        "Talerngsak Kanjanabuch"
    ],
    "citedby-count": 8,
    "ref-count": 26,
    "ref-list": [
        "Treatment and outcome of CPD-associated peritonitis",
        "Recent peritonitis associates with mortality among patients treated with peritoneal dialysis",
        "Peritoneal dialysis-related infections recommendations: 2010 update",
        "ISPD peritonitis recommendations: 2016 update on prevention and treatment",
        "Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis--a randomized controlled trial",
        "Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function",
        "Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis",
        "Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis",
        "Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use",
        "The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin",
        "Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement",
        "Efficacy of antibiotic therapy for peritoneal dialysis-associated peritonitis: a proportional meta-analysis",
        "Sample Size Calculations in Clinical Research",
        "Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes",
        "Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study",
        "Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis",
        "Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis",
        "Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis",
        "Stability of cefepime in peritoneal dialysis solution",
        "Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use",
        "Microbiology and outcomes of peritonitis in North America",
        "Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in South-East Asia",
        "The incidence of peritoneal dialysis-related infection in Thailand: a nationwide survey",
        "Peritoneal dialysis-related peritonitis in southern Thailand",
        "Risk factors of first peritonitis episode in Thai CAPD patients",
        "Retrospective review of neurotoxicity induced by cefepime and ceftazidime"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Brisbane",
            "@id": "60031004",
            "affilname": "The University of Queensland",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031004",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022570",
            "affilname": "Lerdsin Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022570",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60014909",
            "affilname": "Taksin Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014909",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60008902",
            "affilname": "Charoenkrung Pracharak Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008902",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "122914411",
            "affilname": "Nakhon Pathom Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122914411",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Suphanburi",
            "@id": "118735583",
            "affilname": "Chaophrayayommarat Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118735583",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chachoengsao",
            "@id": "117874061",
            "affilname": "Buddhasothorn Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117874061",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "112582720",
            "affilname": "Banphaeo Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112582720",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phayao",
            "@id": "106249955",
            "affilname": "Phayao Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106249955",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Banphaeo Hospital",
        "Buddhasothorn Hospital",
        "Chaophraya Yommarat Hospital",
        "Charoenkrung Pracharak Hospital",
        "Kidney Foundation of Thailand",
        "Nakhonpathom Hospital",
        "Phayao Hospital",
        "Rachadaphicseksompotch Endorsement Fund",
        "Siam Pharmaceutical Co Ltd",
        "Taksin Hospital",
        "Thailand Research Foundation",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "National Research Council of Thailand"
    ]
}